Barrientos, Jacqueline
Mayo Clinic
From Stanford University, Stanford (T.D.S., S.E.C.), the University of California, Irvine, Medical Center, Orange (S.O.), and Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP)-Permanente Medical Group, Oakland (C.C.Z.)
Citations 1
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Shanafelt, Tait D. , Wang, Xin V., Hanson, Curtis A. , Jelinek, Diane F., Braggio, Esteban , Leis, José F., Zhang, Cong C., Coutré, Steven , Cashen, Amanda F. , Mato, Anthony R. , Singh, Avina K., Mullane, Michael P., Little, Richard F. , Stone, Richard M. , Litzow, Mark R. , Tallman, Martin S. , O'Brien, Susan, Barrientos, Jacqueline, Coutre, Steven E, Barr, Paul M , Tallman, Martin, Shanafelt, Tait D , Braggio, Esteban , Kay, Neil E. , O’Brien, Susan , Barrientos, Jacqueline C. , Barr, Paul M. , Erba, Harry Paul
New England Journal of Medicine | July 31, 2019 | Volume: 381 | Issue: 5 | Pages: 432-443
